Analgesics - Senegal | Statista Market Forecast

Senegal's revenue in the Analgesics market in 2024 is estimated to be US$13.99m.
It is projected that the market will experience an annual growth rate of 9.46% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, reaching US$7.24bn in 2024.
Looking at the per person revenues in relation to the total population, in Senegal generates US$0.77 in 2024.
Senegal's analgesics market is witnessing a surge in demand due to increasing prevalence of chronic pain among the aging population.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Senegal is experiencing significant growth due to changing customer preferences and trends in the market. Customer preferences in the Analgesics market in Senegal have shifted towards more natural and herbal remedies. Consumers are becoming increasingly conscious of the ingredients in the products they use and are seeking alternatives to traditional pharmaceuticals. This shift is driven by a desire for more sustainable and eco-friendly options, as well as a growing interest in traditional medicine and natural healing practices. As a result, there has been a rise in demand for analgesic products that are made from natural ingredients and have fewer side effects.Trends in the market also indicate a growing demand for over-the-counter analgesics in Senegal. This can be attributed to several factors, including an aging population and an increase in chronic pain conditions. As the population ages, the prevalence of chronic pain conditions such as arthritis and back pain is on the rise. This has led to an increased need for pain relief medications that can be easily accessed without a prescription. Additionally, the convenience and affordability of over-the-counter analgesics make them a popular choice among consumers.Local special circumstances in Senegal have also contributed to the development of the Analgesics market. The country has a relatively high prevalence of infectious diseases, such as malaria and dengue fever, which can cause symptoms such as fever and body aches. As a result, there is a high demand for analgesics that can provide relief from these symptoms. Furthermore, Senegal has a growing middle class with increased purchasing power, which has led to higher demand for healthcare products, including analgesics.Underlying macroeconomic factors have also played a role in the growth of the Analgesics market in Senegal. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income. This has allowed consumers to spend more on healthcare products, including analgesics. Additionally, the government of Senegal has implemented policies to improve access to healthcare services, which has further boosted demand for analgesics.In conclusion, the Analgesics market in Senegal is developing due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards natural and herbal remedies, the growing demand for over-the-counter analgesics, the prevalence of infectious diseases, and the country's economic growth all contribute to the growth of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.